Explore

Slice the corpus on any axis.

Filter by firm, year, function, metric or slide category — then see the result as a narrative arc, a treemap of slide types, or a catalog of slides.

clear
51,416 slides across 1229 decks match.
Bibliography (2/3)
Kearney · 2020 · appendix
Bibliography (2/3)
Bibliography (3/3)
Kearney · 2020 · appendix
Bibliography (3/3)
CX GLOBAL INSIGHTS 2025
misc · 2025 · cover
CX GLOBAL INSIGHTS 2025
Welcome to CX Global Insights 2025
misc · 2025 · cover
Welcome to CX Global Insights 2025
Summary
misc · 2025 · executive_summary
Summary
The building blocks of CX success
misc · 2025 · framework_other
The building blocks of CX success
For more information
misc · 2025 · closing_ask
For more information
Safe Harbor Statement
GoldmanSachs · 2023 · disclaimer
Safe Harbor Statement
1 Company Overview
GoldmanSachs · 2023 · agenda
1 Company Overview
#FutureFresenius – Operating Companies and Investment Companies
GoldmanSachs · 2023 · other
#FutureFresenius – Operating Companies and Investment Companies
Fresenius Group: Our Healthcare Portfolio
GoldmanSachs · 2023 · other
Fresenius Group: Our Healthcare Portfolio
€19.4 bn — Sales 2022
Fresenius Helios: Health services along the care continuum
GoldmanSachs · 2023 · market_landscape
Fresenius Helios: Health services along the care continuum
€11.7 bn — Sales
Fresenius Medical Care: Dialysis services and products
GoldmanSachs · 2023 · situation_overview
Fresenius Medical Care: Dialysis services and products
€19.4 bn — Sales 2022
Fresenius Vamed: Project business and services
GoldmanSachs · 2023 · situation_overview
Fresenius Vamed: Project business and services
€2.4 bn — Sales
Progressive dividend policy
GoldmanSachs · 2023 · financial_analysis
Progressive dividend policy
0.92 — Dividend per share
Fresenius SE: Fresenius Share & Shareholder Structure
GoldmanSachs · 2023 · kpi_dashboard
Fresenius SE: Fresenius Share & Shareholder Structure
67% — Shareholder structure
Strategic Update
GoldmanSachs · 2023 · section_divider
Strategic Update
#FutureFresenius – Operating Companies and Investment Companies
GoldmanSachs · 2023 · other
#FutureFresenius – Operating Companies and Investment Companies
Scale and impact across a broad range of therapies
GoldmanSachs · 2023 · context
Scale and impact across a broad range of therapies
24m — patients treated
3 Business update Q1/23
GoldmanSachs · 2023 · section_divider
3 Business update Q1/23
4 Financial priorities & Outlook
GoldmanSachs · 2023 · section_divider
4 Financial priorities & Outlook
Outlook for FY/23
GoldmanSachs · 2023 · kpi_dashboard
Outlook for FY/23
FY/23 – Other financial KPIs
GoldmanSachs · 2023 · kpi_dashboard
FY/23 – Other financial KPIs
€15m — EBIT
Attachments
GoldmanSachs · 2023 · appendix
Attachments
Illustrative financial implications from change of Fresenius Medical Care's legal form
GoldmanSachs · 2023 · financial_analysis
Illustrative financial implications from change of Fresenius Medical Care's legal form
-0.9 — IFRS measurement effect
Fresenius Kabi: Q1/23 Organic Revenue Growth by Product Group
GoldmanSachs · 2023 · financial_analysis
Fresenius Kabi: Q1/23 Organic Revenue Growth by Product Group
7% — Organic Revenue Growth
Fresenius Kabi: Q1/23 EBIT(DA) development
GoldmanSachs · 2023 · financial_analysis
Fresenius Kabi: Q1/23 EBIT(DA) development
403 — EBITDA
Fresenius Helios: Q1/23 Key Financials
GoldmanSachs · 2023 · kpi_dashboard
Fresenius Helios: Q1/23 Key Financials
3,066 — Total revenue
Fresenius Helios: Key Metrics
GoldmanSachs · 2023 · kpi_dashboard
Fresenius Helios: Key Metrics
1,433,728 — Admissions
Fresenius Vamed: Q1/23 Key Financials
GoldmanSachs · 2023 · kpi_dashboard
Fresenius Vamed: Q1/23 Key Financials
583 — Total revenue
Fresenius Group: Calculation of Noncontrolling Interests
GoldmanSachs · 2023 · financial_analysis
Fresenius Group: Calculation of Noncontrolling Interests
389 — Net income attributable to Fresenius SE & Co. KGaA
Fresenius Group: Cash Flow
GoldmanSachs · 2023 · financial_analysis
Fresenius Group: Cash Flow
2,499 — Free Cash Flow
Fresenius Group: Reconciliation adjusted Free Cash Flow for CCR
GoldmanSachs · 2023 · financial_analysis
Fresenius Group: Reconciliation adjusted Free Cash Flow for CCR
268 — Adjusted Free Cash Flow for CCR
Cash Flow development Q1/23
GoldmanSachs · 2023 · financial_analysis
Cash Flow development Q1/23
-177 — Free Cash Flow
Cash Flow development Q1/23 LTM
GoldmanSachs · 2023 · financial_analysis
Cash Flow development Q1/23 LTM
2,499 — Free Cash Flow
Revenue by Business Segment – FX, Acquisitions/Divestitures Effects Q1/23
GoldmanSachs · 2023 · data_table
Revenue by Business Segment – FX, Acquisitions/Divestitures Effects Q1/23
10,225 — Revenue
Financial Calendar / Contact
GoldmanSachs · 2023 · next_steps
Financial Calendar / Contact
#FutureFresenius
GoldmanSachs · 2023 · other
#FutureFresenius
Safe harbor statement
MorganStanley · 2021 · disclaimer
Safe harbor statement
Agenda
MorganStanley · 2021 · agenda
Agenda
Agenda
MorganStanley · 2021 · agenda
Agenda
Agenda
MorganStanley · 2021 · agenda
Agenda
Housekeeping items 2021
MorganStanley · 2021 · other
Housekeeping items 2021
€450-500 m — Capex
Contact details Investor Relations
MorganStanley · 2021 · other
Contact details Investor Relations
Abbreviations
MorganStanley · 2021 · appendix
Abbreviations
LANXESS
MorganStanley · 2021 · cover
LANXESS
Generative AI Making Waves
OliverWyman · 2024 · cover
Generative AI Making Waves
Guidance for the road ahead
OliverWyman · 2024 · context
Guidance for the road ahead
Next page →